At a glance
ClinicalIndex Comparison RecordN/ACompleted· 166 enrolled
Drug / intervention
Nasal Implantdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Spirox Latera™ Implant Support of Lateral Nasal Wall Cartilage (LATERAL-OFFICE) Study
In Brief
A clinical study evaluating Nasal Implant for Nasal Obstruction. Completed, enrolled 166 participants across 9 sites.
Detailed Summary
Prospective, multicenter, nonrandomized, single-arm controlled study to obtain outcomes data in participants with severe to extreme class NOSE scores who are undergoing placement of the Spirox Latera Implant with or without concurrent turbinate reduction procedures in an office setting.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNasal Obstruction
CountriesUnited States
CollaboratorsNew Arch Consulting
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartNov 2016
First PostedNov 2016
Primary CompletionMar 2018
Study CompletionAug 2019
TodayJul 2026
First PostedNov 16, 2016
Enrollment StartNov 10, 2016
Primary CompletionMar 21, 2018
Study CompletionAug 29, 2019
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 9.6 years ago
Interventions
Nasal Implantdevice
Latera implant placed as a standalone procedure or in conjunction with a turbinate reduction procedure in an office setting under local anesthesia.